Bloomberg News

Testosterone Drugs May Boost Libidos, Drugmaker Profits

May 02, 2012

Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men who have low levels of testosterone. Doctors warn demand for the treatments could lead to overuse with deadly side effects. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

Running Time: 01:56


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus